Although billions of dollar beauty industry is largely focused on female, women still don’t have approved treatments for some of the health issues. Female sexual dysfunction and baldness are two of them. Ironically, there are most successful treatments for men; Viagra for impotence, Propecia for baldness. This is because of fundamental difference between male and female bodies and the way they work. However, in women baldness, there are some treatments that have been effective but are not clinically approved.
Hair Loss Treatments for Women
Regaine (Minoxidil): Regaine is one of the most successful treatments for baldness. Because baldness is largely seen in men, Regaine hair loss treatment got label of ‘for men’. But, hair loss occurs in women too and needless to say it is disastrous problem for them. Women who are facing hair loss and are desperate to prevent further loss, used Regaine and found it equally effective as compare to men. Regaine works by opening calcium channels and thereby creating more blood capillaries. This leads to more blood and nutrition to hair follicles.
Since the same (calcium channels) found in both males and females, Regaine works for both genders.
Furthermore Regaine is FDA approved and OTC medicine i.e. doctor’s prescription is not required to buy.
Tricomin: It is an alternative option for those who are allergic to Minoxidil. Monoxidil, in few people, causes severe itching. Tricomin, like Regaine, stimulates hair growth but does not cause skin problem. Tricomin contains copper peptides which blocks the chemical reaction that forms a hormone responsible for causing hair loss. Tricomin is also being used for wrinkles and acne. Tricomin is available in many forms, shampoos, sprays and gels, for convenient use. Many men are using Tricomin along with Regaine and Propecia.
Hair Loss Treatment not for Women
Propecia is FDA approved prescription medicine to treat baldness in men. It does not work for women as Propecia works by blocking a hormone not found in women.
Friday, September 3, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment